Avanos Medical – Regulatory Approvals Received for Acquisition

By Greg Peters • Thursday, July 02 13:00 • Permanent Link

Avanos Medical and American Industrial Partners said they have received all required regulatory approvals for the pending acquisition of Avanos by affiliates of AIP’s investment funds, clearing a major hurdle for a deal now expected to close by July 27, 2026.

The companies said the transaction still needs Avanos stockholder approval, with a special meeting set for July 22, 2026 at 9:00 a.m. Eastern time in Atlanta.

The approval news comes just 20 days before the expected closing date, and 5 days before the shareholder vote.

Avanos CEO David C. Pacitti called the regulatory clearance “a significant milestone” and said it moves the company “another step closer” to completing the transaction and entering its next phase of growth.

AIP partner Joel Rotroff said the approvals mark “an important step” toward closing and said AIP expects to support Avanos’s next phase of growth, innovation and commercial execution. Following these announcements, the company's shares moved 1.18%, and are now trading at a price of $24.92. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.